-
Something wrong with this record ?
Scoulerine affects microtubule structure, inhibits proliferation, arrests cell cycle and thus culminates in the apoptotic death of cancer cells
K. Habartova, R. Havelek, M. Seifrtova, K. Kralovec, L. Cahlikova, J. Chlebek, E. Cermakova, N. Mazankova, J. Marikova, J. Kunes, L. Novakova, M. Rezacova,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
Nature Open Access
from 2011-12-01
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
Springer Nature OA/Free Journals
from 2011-12-01
- MeSH
- Enzyme Activation drug effects MeSH
- Apoptosis drug effects MeSH
- Berberine Alkaloids chemistry pharmacology MeSH
- Esters chemistry MeSH
- Phosphorylation drug effects MeSH
- Caspases metabolism MeSH
- Cell Cycle Checkpoints drug effects MeSH
- Carboxylic Acids chemistry MeSH
- Humans MeSH
- Membrane Potential, Mitochondrial drug effects MeSH
- Microtubules drug effects metabolism MeSH
- Cell Line, Tumor MeSH
- Cell Proliferation drug effects MeSH
- Antineoplastic Agents chemistry pharmacology MeSH
- Signal Transduction drug effects MeSH
- Dose-Response Relationship, Drug MeSH
- DNA Breaks drug effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Scoulerine is an isoquinoline alkaloid, which indicated promising suppression of cancer cells growth. However, the mode of action (MOA) remained unclear. Cytotoxic and antiproliferative properties were determined in this study. Scoulerine reduces the mitochondrial dehydrogenases activity of the evaluated leukemic cells with IC50 values ranging from 2.7 to 6.5 µM. The xCELLigence system revealed that scoulerine exerted potent antiproliferative activity in lung, ovarian and breast carcinoma cell lines. Jurkat and MOLT-4 leukemic cells treated with scoulerine were decreased in proliferation and viability. Scoulerine acted to inhibit proliferation through inducing G2 or M-phase cell cycle arrest, which correlates well with the observed breakdown of the microtubule network, increased Chk1 Ser345, Chk2 Thr68 and mitotic H3 Ser10 phosphorylation. Scoulerine was able to activate apoptosis, as determined by p53 upregulation, increase caspase activity, Annexin V and TUNEL labeling. Results highlight the potent antiproliferative and proapoptotic function of scoulerine in cancer cells caused by its ability to interfere with the microtubule elements of the cytoskeleton, checkpoint kinase signaling and p53 proteins. This is the first study of the mechanism of scoulerine at cellular and molecular level. Scoulerine is a potent antimitotic compound and that it merits further investigation as an anticancer drug.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19035342
- 003
- CZ-PrNML
- 005
- 20191008113028.0
- 007
- ta
- 008
- 191007s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-018-22862-0 $2 doi
- 035 __
- $a (PubMed)29555944
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Habartova, Klara $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Simkova 870, Hradec Kralove, 500 03, Czech Republic.
- 245 10
- $a Scoulerine affects microtubule structure, inhibits proliferation, arrests cell cycle and thus culminates in the apoptotic death of cancer cells / $c K. Habartova, R. Havelek, M. Seifrtova, K. Kralovec, L. Cahlikova, J. Chlebek, E. Cermakova, N. Mazankova, J. Marikova, J. Kunes, L. Novakova, M. Rezacova,
- 520 9_
- $a Scoulerine is an isoquinoline alkaloid, which indicated promising suppression of cancer cells growth. However, the mode of action (MOA) remained unclear. Cytotoxic and antiproliferative properties were determined in this study. Scoulerine reduces the mitochondrial dehydrogenases activity of the evaluated leukemic cells with IC50 values ranging from 2.7 to 6.5 µM. The xCELLigence system revealed that scoulerine exerted potent antiproliferative activity in lung, ovarian and breast carcinoma cell lines. Jurkat and MOLT-4 leukemic cells treated with scoulerine were decreased in proliferation and viability. Scoulerine acted to inhibit proliferation through inducing G2 or M-phase cell cycle arrest, which correlates well with the observed breakdown of the microtubule network, increased Chk1 Ser345, Chk2 Thr68 and mitotic H3 Ser10 phosphorylation. Scoulerine was able to activate apoptosis, as determined by p53 upregulation, increase caspase activity, Annexin V and TUNEL labeling. Results highlight the potent antiproliferative and proapoptotic function of scoulerine in cancer cells caused by its ability to interfere with the microtubule elements of the cytoskeleton, checkpoint kinase signaling and p53 proteins. This is the first study of the mechanism of scoulerine at cellular and molecular level. Scoulerine is a potent antimitotic compound and that it merits further investigation as an anticancer drug.
- 650 _2
- $a protinádorové látky $x chemie $x farmakologie $7 D000970
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a berberinové alkaloidy $x chemie $x farmakologie $7 D001600
- 650 _2
- $a kyseliny karboxylové $x chemie $7 D002264
- 650 _2
- $a kaspasy $x metabolismus $7 D020169
- 650 _2
- $a kontrolní body buněčného cyklu $x účinky léků $7 D059447
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a zlomy DNA $x účinky léků $7 D053960
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a aktivace enzymů $x účinky léků $7 D004789
- 650 _2
- $a estery $x chemie $7 D004952
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a membránový potenciál mitochondrií $x účinky léků $7 D053078
- 650 _2
- $a mikrotubuly $x účinky léků $x metabolismus $7 D008870
- 650 _2
- $a fosforylace $x účinky léků $7 D010766
- 650 _2
- $a signální transdukce $x účinky léků $7 D015398
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Havelek, Radim $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Simkova 870, Hradec Kralove, 500 03, Czech Republic. havelekr@lfhk.cuni.cz.
- 700 1_
- $a Seifrtova, Martina $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Simkova 870, Hradec Kralove, 500 03, Czech Republic.
- 700 1_
- $a Kralovec, Karel $u Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentska 573, Pardubice, 532 10, Czech Republic.
- 700 1_
- $a Cahlikova, Lucie $u ADINACO Research group, Department of Pharmaceutical Botany and Ecology, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, Hradec Kralove, 500 05, Czech Republic.
- 700 1_
- $a Chlebek, Jakub $u ADINACO Research group, Department of Pharmaceutical Botany and Ecology, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, Hradec Kralove, 500 05, Czech Republic.
- 700 1_
- $a Cermakova, Eva $u Department of Medical Biophysics, Faculty of Medicine in Hradec Kralove, Charles University, Simkova 870, Hradec Kralove, 500 03, Czech Republic.
- 700 1_
- $a Mazankova, Nadezda $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Simkova 870, Hradec Kralove, 500 03, Czech Republic.
- 700 1_
- $a Marikova, Jana $u Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, Hradec Kralove, 500 05, Czech Republic.
- 700 1_
- $a Kunes, Jiri $u Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, Hradec Kralove, 500 05, Czech Republic.
- 700 1_
- $a Novakova, Lucie $u Department of Analytical Chemistry, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, Hradec Kralove, 500 05, Czech Republic.
- 700 1_
- $a Rezacova, Martina $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Simkova 870, Hradec Kralove, 500 03, Czech Republic.
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 8, č. 1 (2018), s. 4829
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29555944 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191008113444 $b ABA008
- 999 __
- $a ok $b bmc $g 1452002 $s 1073892
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 8 $c 1 $d 4829 $e 20180319 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20191007